We sincerely welcome Prof. Dr. Alberto Priori from University of Milan, Italy, to join the Editorial Board of OBM Neurobiology. He has more than 440 publications. We appreciate Prof. Dr. Alberto Priori for his participation and support.

We sincerely welcome Prof. Dr. Giuseppe Biagini from University of Modena and Reggio Emilia, Italy, to join the Editorial Board of OBM Neurobiology. He has more than 150 publications. We appreciate Prof. Dr. Giuseppe Biagini for his participation and support.

We sincerely welcome Dr. Fady Alnajjar from United Arab Emirates University, UAE, to join the Editorial Board of OBM Neurobiology. Dr. Alnajjar is an Associate Professor of the Department of Computer Science and Software Engineering at United Arab Emirates University. He has extensive experience in signal processing, behavior analysis, motor learning and motor control, artificial intelligence, brain, rehabilitation robotics, neural networks, and cognitive training. We are grateful to Dr. Alnajjar for his participation and support.

We sincerely welcome Dr. Sergey Bachurin the full member of Russian Academy of Sciences, Russian Federation, to join the Editorial Board of OBM Neurobiology. He has completed his PhD and Dr. Sci. Degree in Moscow State University, Russia. In 1992 and in 1995 he had been working in the University San Francisco and in Taft’s University (USA). Since 2006 till 2019 he was a director of the Institute of Physiologically Active Compounds, Russian Academy of Science in Chernogolovka, Russia. Since 2001 till present he is the Head of Department of Medicinal and Biological Chemistry of the IPAC RAS. He has published more than 250 papers in reputed journals and about 40 patents, and has been serving as an editorial board member of repute. We appreciate Dr. Sergey Bachurin for his participation and support.

We sincerely welcome Dr. Iain P Hargreaves from Liverpool John Moores University, UK, to join the Editorial Board of OBM Neurobiology. Dr. Iain P Hargreave is an expert in neuroscience and mitochondrial disease. He has more than 180 publications. We appreciate Dr. Iain P Hargreaves for his participation and support.

We sincerely welcome Dr. Maurizio Elia from IRCCS Oasi Maria SS., Italy, to join the Editorial Board of OBM Neurobiology. His main research interests are electroencephalography, neurology, epilepsy, and brain. We appreciate Dr. Maurizio Elia for his participation and support.

It is our pleasure to announce that LIDSEN has joined the ORCID community. ORCID (Open Researcher and Contributor ID), a global, not-for-profit organization, provides a free, unique, and persistent digital identifier (an ORCID iD), which can automatically link researchers to their own contributions, so as to disambiguate researchers from one another. Authors who publish with OBM Neurobiology are greatly encouraged to register for a unique iD to ensure proper attribution.

We sincerely welcome Dr. Jasmin from University of California San Francisco, United States, to join the Editorial Board of OBM Neurobiology. Dr. Jasmin has extensive experience in: pain, stress, theentericnervous system, primary sensory neurons, dorsal root ganglion, pharmacology, GABA, glutamate, TRPM8, and health care economics and policies, etc. We are sincerely grateful to Dr. Jasmin for his participation and support.

We sincerely welcome Dr. Khan from University of Tennessee Health Science Center, United States, to join the Editorial Board of OBM Neurobiology. Dr. Khan has extensive experience in: neuroscience, pharmacology, neurodegeneration, neuroinflammation, Parkinson’s disease, stroke; Alzheimer’s disease, multiple sclerosis and traumatic brain injury, etc. We are sincerely grateful to Dr. Khan for his participation and support.

We sincerely welcome Dr. Sabine M. Hölter, from Helmholtz Zentrum München and Technical University Munich, Germany, to join the Editorial Board of OBM Neurobiology. Dr. Hölter has abundant professional experience in behavioral neuroscience, neuropsychiatric diseases, neurodegeneration, molecular neurogenetics, mouse phenotyping, neuropharmacology, neurobiology and brain physiology, etc. We appreciate Dr. Hölter for her participation and support.

We sincerely welcome Dr. Viscomi from IRCCS Fondazione Santa Lucia, Italy, to join the Editorial Board of OBM Neurobiology. Dr. Viscomi has extensive experience in: neurodegenerative disease, brain injury, neuroscience biochemistry, etc. We are sincerely grateful to Dr. Viscomi for her participation and support.

We sincerely welcome Professor Reale, from “G.d’Annunzio” University, Italy, to join the Editorial Board of OBM Neurobiology. Professor Reale has abundant professional experience in inflammation, cytokines, neurodegenerative disease, neuroinflammation, autoimmune diseases, probiotics and inflammation, etc. We appreciate Professor Reale for her participation and support.

We sincerely welcome Professor Campolongo from Universita degli Studi di Roma La Sapienza, Italy, to join the Editorial Board of OBM Neurobiology. Professor Campolongo has extensive experience in: neurobiology, neuropsychopharmacology, behavioral neuroscience, neuropharmacology, behavioral testing, behavioral pharmacology, cannabinoid research, etc. We are sincerely grateful to Professor Campolongo for her participation and support.

We sincerely welcome Professor Beran from Griffith University, Australia, to join the Editorial Board of OBM Neurobiology. Professor Beran has extensive experience in: sleep, health law & ethics, epilepsy, sleep disorders, drug trials, legal medicine, neurological conditions & new therapies, neurological advances, etc. We are sincerely grateful to Professor Beran for his participation and support.

We sincerely welcome Dr. Lanciego, from University of Navarra Medical School, Spain, to join the Editorial Board of OBM Neurobiology. Dr. Lanciego has abundant professional experience in basal ganglia anatomy, Parkinson's disease and related synucleinopathies, glucocerebrosidase, GPCR receptors, alpha-synuclein, gene therapy, neurodegeneration, nonhuman primates, etc. We appreciate Dr. Lanciego for his participation and support.

We sincerely welcome Dr. Kozicz, from University of Mayo Clinic, Minnesota, to join the Editorial Board of OBM Neurobiology. Dr. Kozicz has abundant professional experience in animal models of stress-related mood disorders, neurobiology of stress, urocortin, corticotropin releasing factor, energy metabolism, mitochondria, depression, post-traumatic stress disorder, anxiety, etc. We are sincerely grateful to Dr. Kozicz for his participation and support.

We sincerely welcome Professor Reynolds from Texas A & M University, United States, to join the Editorial Board of OBM Neurobiology. Professor Reynolds has extensive experience in: psychology, social Sciences, neuroscience, psychological testing and assessment, health professions, etc. We are sincerely grateful to Professor Reynolds for his participation and support.

We sincerely welcome Professor Koch from University of Bremen, Germany, to join the Editorial Board of OBM Neurobiology. Professor Koch has extensive experience in: cognitive neuroscience, learning and memory, brain, behavioral neuroscience, neuropharmacology, neurobiology and brain physiology, behavioral testing, etc. We are sincerely grateful to Professor Koch for his participation and support.

We sincerely welcome Professor Brown from University of Nevada, United States, to join the Editorial Board of OBM Neurobiology. Professor Brown has extensive experience in: psychology, clinical and pediatric psychology, neuroscience, attention disorders, health professions, etc. We are sincerely grateful to Professor Brown for his participation and support.

We sincerely welcome Professor Robert Zorec from University of Ljubljana, Medical Faculty, Slovenia, to join the Editorial Board of OBM Neurobiology. Professor Zorec has extensive experience in cell physiology and pathophysiology, biophysics, neuroscience, neuroglia, neurodegeneration, neurodevelopmental disorders, neuroinflammaton and neurotrauma. We are sincerely grateful to Professor Zorec for his participation and support.

We sincerely welcome Dr Barbara Picconi, from IRCCS Fondazione Santa Lucia, Italy, to join the Editorial Board of OBM Neurobiology. Dr. Picconi has abundant professional experience in electrophysiology, neurodegenerative disorders, neuroscience, experimental models of parkinson's disease, levodopa-induced dyskinesia. We appreciate Dr. Picconi for her participation and support.

We sincerely welcome Dr. Weiwen Wang, from Institute of Psychology, China, to join the Editorial Board of OBM Neurobiology. Dr. Wang has abundant professional experience in early stress, depression, schizophrenia, cognitive dysfunction, psychoneuroimmunology, molecular neuroscience. We appreciate Dr. Wang for his participation and support.

We sincerely welcome Dr. Luigi De Gennaro, from University of Rome Sapienza, Italy, to join the Editorial Board of OBM Neurobiology. Dr. Gennaro has abundant professional experience in sleep, sleep in neurodegenerative diseases, sleep regulation, neurophysiology of sleep, sleep disorders, dream recall, ontogenetic aspects of sleep, sleepiness, sleep deprivation. We appreciate Dr. Gennaro for his participation and support.

We sincerely welcome Professor Bart Ellenbroek, from Victoria University of Wellington, New Zealand, to lead the journal OBM Neurobiology as the Editor-in-Chief. Professor Ellenbroek is an expert specializing in behavioural neurogenetics. He and his group focus on the aetiology and neurobiology of symptoms related to several psychiatric disorders. We are grateful to Professor Ellenbroek for his participation and support.

We sincerely welcome Dr. Guodong Cao, from University of Pittsburgh, USA, to join the Editorial Board of OBM Neurobiology. Dr. Cao and his team seek to research on neuronal cell death mechanism, neurovascular remodeling, white matter injury and stem cell therapy in ischemic stroke and exploration of therapeutic approaches for the treatment of ischemic stroke. We appreciate Dr. Cao for his participation and support.

We sincerely welcome Professor Sangeeta Singg, from Angelo State University, USA, to join the Editorial Board of OBM Neurobiology. Professor Singg has abundant professional experience in post-traumatic stress disorder, depression, zoophilia, childhood sexual abuse, memory, cardiovascular disease, alternative methods of healing, grief, suicide, energy medicine, student personal responsibility, self-esteem, color preference and color therapy, role of nutrition in physical and psychological wellness. Dr. Singg organized the first AIDS Awareness Program in West Texas in early 1980s and started the first support group for the AIDS patients, their families and friends. We appreciate Professor Singg for her participation and support.

We sincerely welcome Dr. Michael C. Wu, from University of California, San Diego, USA and President of Neurodigitech, to join the Editorial Board of OBM Neurobiology. Dr. Wu and his team seek to develop the high-throughput digital imaging platform to disclose the diversity of morphological properties and identify the best therapeutic biomarkers for neurodegenerative diseases. Moreover, his additional effort has been dedicated to the development of effective brain-computer-interface (BCI) devices for the early diagnosis of TBI (traumatic brain injury). We appreciate Dr. Wu for his participation and support.

We sincerely welcome Professor Mirela Olympia Fagarasan Palmer, from University of South California, USA, to join the Editorial Board of OBM Neurobiology. Professor Palmer and her team seek to understand the fundamental neurobiological mechanisms of neuropsychiatric disorders to contribute at development of new pharmacological treatments. We appreciate Professor Palmer for her participation and support.

We sincerely welcome Professor Miguel A Pappolla, from the University of Texas Medical Branch, Galveston, TX, and the Texas Medical Center at Houston, TX, USA, to join the Editorial Board of OBM Neurobiology. Professor Pappolla and his team was among the first to identify evidence of oxidative stress in Alzheimer's disease brain, conducted groundbreaking research on hypercholesterolemia as an early risk factor for Alzheimer's disease. His research involves the development of neuroprotective drugs as potential therapeutic agents. Dr. Pappolla's lab identified of several naturally occurring neuroprotective substances. This discovery provides a biochemical basis, at least in part, for the gut-brain axis. We appreciate Professor Pappolla for his participation and support.

We sincerely welcome Professor Eva MARÍA Arroyo-Anlló, from University of Salamanca, Spain, to join the Editorial Board of OBM Neurobiology. Professor Arroyo-Anlló and her team seek to understand the neuropsychology in Alzheimer's disease, particularly, the memory, cognitive stimulation, and consciousness. We appreciate Professor Arroyo-Anlló for her participation and support.